2-232457014-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001631.5(ALPI):c.416A>C(p.Gln139Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,500 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001631.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALPI | NM_001631.5 | c.416A>C | p.Gln139Pro | missense_variant | Exon 4 of 11 | ENST00000295463.4 | NP_001622.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALPI | ENST00000295463.4 | c.416A>C | p.Gln139Pro | missense_variant | Exon 4 of 11 | 1 | NM_001631.5 | ENSP00000295463.3 | ||
ALPI | ENST00000457560.1 | n.*345A>C | non_coding_transcript_exon_variant | Exon 3 of 10 | 5 | ENSP00000413068.1 | ||||
ALPI | ENST00000457560.1 | n.*345A>C | 3_prime_UTR_variant | Exon 3 of 10 | 5 | ENSP00000413068.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000758 AC: 19AN: 250636Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135730
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461296Hom.: 0 Cov.: 34 AF XY: 0.0000275 AC XY: 20AN XY: 726954
GnomAD4 genome AF: 0.000131 AC: 20AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.416A>C (p.Q139P) alteration is located in exon 4 (coding exon 4) of the ALPI gene. This alteration results from a A to C substitution at nucleotide position 416, causing the glutamine (Q) at amino acid position 139 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at